Viewing Study NCT05394493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT05394493
Status: COMPLETED
Last Update Posted: 2023-12-06
First Post: 2022-05-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module